Edition:
United States

Juniper Pharmaceuticals Inc (JNP.OQ)

JNP.OQ on NASDAQ Stock Exchange Global Select Market

5.10USD
13 Dec 2017
Change (% chg)

$0.15 (+3.03%)
Prev Close
$4.95
Open
$4.95
Day's High
$5.15
Day's Low
$4.95
Volume
3,687
Avg. Vol
4,490
52-wk High
$6.10
52-wk Low
$3.65

Chart for

About

Juniper Pharmaceuticals, Inc. is a women’s health therapeutics company. The Company is focused on developing therapeutics that address unmet medical needs in women’s health. It operates in two segments: product and service. The product segment is engaged in manufacturing and supplying CRINONE, the Company’s commercialized... (more)

Overall

Beta: 0.03
Market Cap(Mil.): $55.30
Shares Outstanding(Mil.): 10.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.96 15.25
EPS (TTM): -- -- --
ROI: -- 15.07 33.27
ROE: -- 16.58 16.35

BRIEF-Juniper Pharmaceuticals reports third quarter results

* Juniper Pharmaceuticals reports third quarter 2017 financial and operating results

Nov 02 2017

BRIEF-Juniper Pharmaceuticals announces strategic reprioritization

* Juniper Pharmaceuticals announces strategic reprioritization

Sep 18 2017

Competitors

Earnings vs. Estimates